The successful transplant of a gene-edited pig kidney into a human patient has raised hopes that cutting-edge technology can make pig organs safe for other patients.
Towana Looney, a 53-year-old grandmother from Alabama whose (only) kidney was failing, is hopeful of "a new chance at life" after undergoing the still-experiment procedure, said NBC News.
What does gene editing do? The goal of gene editing is to "bridge the species gap" and "keep the human immune system from immediately attacking the foreign tissue", said The Independent.
Multiple companies are already "engineering pigs to be more humanlike" for optimal organ-transplant suitability, said The Associated Press. These engineered pigs could "someday provide an unlimited supply of kidneys, livers, hearts, and other organs" for human transplantation, alleviating the current "chronic shortage" and saving "thousands of patients every year", said NPR.
What is the legal status of animal-organ transplants? No specific legislation prohibits xenotransplantation – the transplantation of living cells, tissues or organs from one species to another – in the UK, but there are animal welfare laws that touch on the issue. In the US, the Food and Drug Administration (FDA) can permit "compassionate-use" xenotransplants for patients who would not be able to receive a human donor organ in time to save their life.
What are the risks? The current "series of one-off experiments", each using "different protocols, organs with different gene edits, and patients who have run out of options", is "not a great way to do science", L. Syd M Johnson, a bioethicist at SUNY Upstate Medical University in New York, told NPR.
Nor is it clear if enough is being done "to prevent the spread of pig viruses to people", according to Johnson. It is "impossible to predict what the public-health implications might be" if that happens.
What next? Following the success of Looney's operation, two companies are hoping to get FDA permission to "begin the world's first clinical trials" in 2025, said The Independent. Even then, "it will take years of clinical trials to prove whether xenotransplantation really could work", said AP. But if it does, "porcine technology" companies envisage large facilities, "capable of producing up to 2,000 organs a year, in several places around the country". |